Abbott Laboratories Pakistan Limited (ABOT): 9MCY23 Corporate Briefing Takeaways – By Taurus Research
<p></p><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">Abbott Laboratories Pakistan Limited is one of the leading
pharmaceutical players in Pakistan, having two manufacturing facilities and a
product portfolio of above 150 products. The Company majorly operates in the
Pharmaceuticals segment, Nutritional Segment, and Diagnostics segment.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">During CY22, sales revenue increased by ~16%YoY to clock-in
at ~PKR 49Bn. Segment-wise revenue growth of Pharmaceuticals, Nutritional,
Diagnostic, and others arrived at 14%, 23%, 9%, and 9%, respectively. However,
the gross profit fell ~9pptsYoY, being adversely impacted by exchange rate
fluctuations coupled with higher inflation and the inability to pass on cost
impact...
